Zacks Investment Research cut shares of Option Care Health (NASDAQ:OPCH) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports.
According to Zacks, “Option Care Health Inc provides infusion and home care management solutions. The Company offers products, services and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders and heart failures. Option Care Health Inc., formerly known as BioScrip Inc., is based in Denver, United States. “
OPCH has been the subject of several other research reports. BidaskClub cut Option Care Health from a buy rating to a hold rating in a research note on Friday, December 18th. ValuEngine lowered shares of Option Care Health from a buy rating to a hold rating in a research report on Tuesday, December 1st. Canaccord Genuity lifted their price objective on shares of Option Care Health from $18.00 to $20.00 and gave the stock a buy rating in a research note on Wednesday, November 4th. Finally, The Goldman Sachs Group initiated coverage on shares of Option Care Health in a research note on Tuesday, December 15th. They set a neutral rating and a $18.00 target price for the company. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Option Care Health currently has a consensus rating of Buy and an average price target of $19.00.
OPCH stock opened at $16.78 on Wednesday. The stock’s 50 day simple moving average is $15.59 and its 200 day simple moving average is $13.59. Option Care Health has a 12-month low of $5.74 and a 12-month high of $18.21. The firm has a market cap of $3.13 billion, a P/E ratio of -32.27 and a beta of 1.04. The company has a current ratio of 1.62, a quick ratio of 1.24 and a debt-to-equity ratio of 1.47.
Option Care Health (NASDAQ:OPCH) last released its earnings results on Sunday, November 8th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.04) by $0.05. Option Care Health had a negative net margin of 3.10% and a negative return on equity of 4.05%. The firm had revenue of $781.60 million during the quarter, compared to analyst estimates of $720.53 million. The business’s revenue was up 331.8% on a year-over-year basis. On average, research analysts forecast that Option Care Health will post -0.17 EPS for the current fiscal year.
In other Option Care Health news, Director Elizabeth Quadros Betten sold 10,000,000 shares of the company’s stock in a transaction dated Monday, December 14th. The shares were sold at an average price of $15.00, for a total transaction of $150,000,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 80.90% of the stock is currently owned by insiders.
A number of institutional investors have recently bought and sold shares of OPCH. Truist Financial Corp acquired a new stake in Option Care Health during the 3rd quarter valued at $2,711,000. Bank of America Corp DE raised its position in Option Care Health by 26.7% during the second quarter. Bank of America Corp DE now owns 51,608 shares of the company’s stock valued at $716,000 after buying an additional 10,860 shares during the period. Sei Investments Co. lifted its stake in Option Care Health by 19.7% in the 2nd quarter. Sei Investments Co. now owns 328,449 shares of the company’s stock worth $4,559,000 after acquiring an additional 54,026 shares in the last quarter. New York State Common Retirement Fund boosted its position in Option Care Health by 69.8% during the 3rd quarter. New York State Common Retirement Fund now owns 561,106 shares of the company’s stock worth $7,502,000 after acquiring an additional 230,676 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its position in Option Care Health by 15.8% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 26,890 shares of the company’s stock worth $360,000 after acquiring an additional 3,671 shares during the period. 14.22% of the stock is owned by hedge funds and other institutional investors.
About Option Care Health
Option Care Health, Inc provides independent home and alternate site infusion services in the United States. The company offers immunoglobulin infusion therapy designed for the treatment of immune deficiencies; anti-infective therapy and services; infusion therapies for bleeding disorders; and other infusion therapies to treat various conditions, including heart failure, pain management, chemotherapy, and respiratory medications.
Featured Story: What is a Secondary Public Offering?
Get a free copy of the Zacks research report on Option Care Health (OPCH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com